Stable pressurized aerosol solution composition of glycopyrronium bromide and formoterol combination

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10617669
APP PUB NO 20160303044A1
SERIAL NO

15196253

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Aerosol solution compositions intended for use with a pressurized metered dose inhaler, comprising glycopyrronium bromide and formoterol, or a salt thereof, optionally in combination with one or more additional active ingredients, and stabilized by a selected amount of a mineral acid, exhibit improved stability when contained in an aerosol can provided with a metering valve having at least a butyl rubber gasket.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIESI FARMACEUTICI S P AVIA PALERMO 26/A PARMA 43122

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bonelli, Sauro Parma, IT 23 129
Copelli, Diego Parma, IT 8 38
Dagli, Alberi Massimiliano Parma, IT 4 10
Usberti, Francesca Parma, IT 21 107
Zambelli, Enrico Parma, IT 24 131

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Oct 14, 2027
11.5 Year Payment $7400.00 $3700.00 $1850.00 Oct 14, 2031
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00